
Uncoated
Plain and scored tablets for high-volume, cost-efficient supply.
Conventional, coated, modified-release and multi-layer tablets, made across seven manufacturing units in four locations, so your supply never depends on a single site.

From high-volume conventional tablets to complex multi-layer designs that combine two actives with different release profiles in one dose.

Plain and scored tablets for high-volume, cost-efficient supply.

A thin polymer coat for stability, easier swallowing and brand colour.

Classic smooth, glossy coating that masks bitter taste.

Controlled release over hours for once-daily dosing and better adherence.

Pleasant-tasting tablets for children, older patients and anyone who prefers not to swallow.

Dissolves in water for fast onset and easy dosing.

Two layers, two actives or two release speeds, kept apart in one tablet.

A core tablet inside an outer tablet for immediate plus sustained relief.

Our most complex design: a two-layer core within an outer release layer.

Made in humidity-controlled suites for moisture-sensitive actives such as clavulanate.

Small round dosage units, including oral hormonal pills.

Combination packs that bring multiple tablets together in one regimen.
Sustained, extended and dual-release profiles designed to cut dosing frequency.
Bilayer, tablet-in-tablet and bilayered tablet-in-tablet for fixed-dose combinations.
Low-RH manufacturing suites for actives that degrade with moisture.
Dedicated units for penicillins, cephalosporins, hormones and steroids.
A few of the tablet formulations we have developed, patented or taken through approval.
A dual-release tablet-in-tablet for nausea and vomiting in pregnancy, with immediate and sustained relief in one dose.
Our first UK approval, with Akums as the marketing authorisation holder.
Contraceptive pills and HRT tablets certified for supply across Eurasian Economic Union markets.
Sustained-release tablets for managing postherpetic neuralgia.
A dual-action fixed-dose combination tablet for type 2 diabetes.
A combination of two sustained-release actives for type 2 diabetes.
Pick a format to see which units make it and what approvals each one holds. That way you can plan a primary site and a backup that suits your market.
7 units across 4 locations make tablets.

Conventional and coated tablets, alongside capsules and sachets.

Hormonal tablets, including contraceptive pills and HRT tablets, plus hormonal kits.

Nutraceutical and Ayurvedic tablets, alongside capsules, liquids, powders and gummies.

Low-RH tablets, tablet-in-tablet, bilayer tablets and kits.

Penicillin tablets (bilayer, sustained-release and low-RH), cephalosporin tablets and steroid tablets, each in a segregated unit.

Tablets, with a dedicated oral penam facility for low-RH tablets.

General tablets and steroid tablets, alongside capsules, liquids and ointments.
Multi-site capability protects your supply from a single-point failure, whether it's a capacity crunch, an audit or a disruption.
Units in Haridwar, Roorkee and Kotdwar in Uttarakhand, and in Baddi, Himachal Pradesh.
See up front which unit is cleared for your target market before you plan a second source.
Our teams handle transfer and validation when you add a site.
A dedicated stability facility supports products from every unit.

And many more, backed by regulatory approvals across more than 60 countries.
Partner with Akums to elevate your pharmaceutical, nutraceutical, and cosmetic supply chain. As India's leading CDMO, we offer end-to-end solutions, including R&D, formulation development, and large-scale manufacturing. Our state-of-the-art facilities comply with stringent global standards, ensuring product safety, efficacy, and quality. With a strong focus on innovation, we deliver tailored solutions to meet your unique business needs. Whether you're launching a new product or enhancing your current supply chain, Akums provides reliable expertise, seamless scalability, and unwavering commitment to excellence. Join hands with Akums to strengthen your brand and achieve sustained growth in competitive markets.